Schedule 13D ownership disclosure
LIPELLA PHARMACEUTICALS INC
Security class unavailable · CUSIP: 53630L100
Event date: 2024-03-04
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 18.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001753926-24-000480
- Form type
- SC 13D
- Filer
- Chancellor Michael B
- CIK
- CIK 1959360
- Filed
- Mar 06, 2024
- Reporting period
- Mar 04, 2024
- Description
- Schedule 13D beneficial ownership